FOP Australia is excited to announce the upcoming commencement of the phase 3 clinical trial of Palovarotene in Brisbane later this month.
This is a big achievement for the Fibrodysplasia Ossificans Progressiva community in Australia and we are thankful for everyone that has been involved to make this a reality.
Professor Matt Brown, Dr Ben Whitehead, and Ms Linda Bradbury are delighted to be working with FOP Australia in enabling Australia’s FOP community to get access to effective treatment for FOP through this clinical trial.
The above image was made for Rare Disease Day 28th February 2018 based on input from the Australian FOP community as words that give them hope.